Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Post by CorporateRebelon Oct 16, 2018 12:16pm
103 Views
Post# 28810714

Overvalued? Really?

Overvalued? Really? Let's get one thing clear, P/E ratios are not for growth stage companies. Any company in a growth sector that is PROFITABLE, is not scaling appropriately, and would actually worry me. A company that is leveraging all of their fiscal resources to grow, is a company that will scale. 

Overvalued...there are many other stocks other than Cannabis that are "overvalued". if you are looking for textbook technical ratios, go look into mining and financial services, emerging tech/cannabis/growth sectors are not for you. 


Amazon trading at a 4.5 price to sales ratio... 

Aurora with 220m this Q, lets say 1B a year revenue. This gives it a 4.5B valuation this year, fair value based on emerging tech multiples (which are more risky than MJ, given mj is a retail product, and a commodity good that is a raw input into other products as well)

The edible market, drink market, and medicinal derivatives have not even been priced into this 4.5 B valuation. We are trading about 3 times this year's revenue.

Anyone sensible will know that unlike Amazon, we are not competing to create a market, we are competing to realize it. It will be much easier to sell edibles and drinks with mj than it is to dirsupt the traditional grocery shopping business. triple the growth over the next few years is not unreasonable. 

So...for the traders, do what you have to do. They are here to trade on volatility. THey are not here to value invest. 

Longs...it may be a while before the market matures...but 3-4 years down the road we'll definitely see some additional hype based on the pace of growth. Exciting times ahead...this industry is not crashing for long. 
Bullboard Posts